| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/09/2007 | CN1958000A Method for processing rhizoma coptidis |
| 05/09/2007 | CN1957989A Compound soft capsule of olive oil, astragalus |
| 05/09/2007 | CN1957984A Capsule bubbles in use for treating allergic rhinitis, and preparation method |
| 05/09/2007 | CN1957956A Composition of multiple fungus possessing effects of anti tumour and adjusting immunity preparation method, and usage |
| 05/09/2007 | CN1957953A Composition of multiple fungus possessing immunoloregulation function, preparation method and usage |
| 05/09/2007 | CN1957944A Application of yew amylose in pharmacy |
| 05/09/2007 | CN1957942A External preparation of Levocetirizine hydrochloric acid |
| 05/09/2007 | CN1957941A External preparation of Fexofenadine |
| 05/09/2007 | CN1957927A Fat micro sphere preparation of triterpenoid saponin and derivative, and fabricating method |
| 05/09/2007 | CN1314963C Substance containing shiitake mushroom hypha extract for soreening LAK activity and method for screening LAK activity by using the same |
| 05/09/2007 | CN1314712C Preparation for fungus extracellular polysaccharide compound and application thereof |
| 05/09/2007 | CN1314696C 2-O-(beta-D-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 05/09/2007 | CN1314683C Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
| 05/09/2007 | CN1314450C Multicomponent vaccines |
| 05/09/2007 | CN1314448C Medical use and medicinal preparation of trichonema in preventing human and animals from diseases by immunologic inadequacy |
| 05/09/2007 | CN1314426C Medicine for treating chronic hives |
| 05/09/2007 | CN1314403C Composition of paeoniflorin and albiflorin and its preparation method |
| 05/09/2007 | CN1314400C Solid preparation taken through oral cavity of compound MEthoxyphEnaminE and preparation method |
| 05/09/2007 | CN1314386C Tripterygium hypoglaucum contained transdermal plaster and its preparation |
| 05/08/2007 | USRE39614 Canine IL-4 immunoregulatory proteins and uses thereof |
| 05/08/2007 | US7214800 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
| 05/08/2007 | US7214798 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; analgesics |
| 05/08/2007 | US7214772 Sialoadhesin family member-2 (SAF-2) |
| 05/08/2007 | US7214716 Hypotensive agents; antiinflammatory agents; gastrointestinal disorders; autoimmune disease; 4-phenyl pinene derivatives |
| 05/08/2007 | US7214710 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 05/08/2007 | US7214700 Administering to a human patient an 2-oxindole-3-ylidenyl) acetic acid derivatives which modulate the activity of protein kinases and effective to treat disorders related to abnormal protein kinase activity, such as cancer |
| 05/08/2007 | US7214689 Isoquinoline compounds |
| 05/08/2007 | US7214688 Compounds |
| 05/08/2007 | US7214680 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors |
| 05/08/2007 | US7214677 Benzamide, heteroarylamide and reverse amides |
| 05/08/2007 | US7214676 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 05/08/2007 | US7214675 Administering the compound N-{2-[2-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)ethoxy]ethyl}morpholine-4-carboxamide inducing cytokine biosynthesis; Viricides; anticancer agents; immunology moderators |
| 05/08/2007 | US7214393 Administering an anti-allergy composition of a wood-vinegar distilled solution, colorless and transparent |
| 05/08/2007 | US7214380 Composition of an allergen that causes Th2-type T cell response in a susceptible individual, Listeria adjuvant, and a pharmaceutically acceptable carrier; treating allergies associated with an established allergen specific Th2-type T cell response |
| 05/08/2007 | US7214373 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 05/08/2007 | CA2443216C Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine |
| 05/08/2007 | CA2385872C Gene transfer in human lymphocytes using retroviral scfv cell targeting |
| 05/08/2007 | CA2373990C Pyrrolotriazine inhibitors of kinases |
| 05/08/2007 | CA2310593C Metalloproteinase inhibitors |
| 05/08/2007 | CA2293612C Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 05/08/2007 | CA2273824C Mutants of streptococcal toxin c and methods of use |
| 05/03/2007 | WO2007050375A2 Piperazine derivatives useful as ccr5 antagonists |
| 05/03/2007 | WO2007049917A1 The composition comprising extract of cinnamomum cassia bark for improving normal flora and enhancing immune response |
| 05/03/2007 | WO2007049819A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient |
| 05/03/2007 | WO2007049771A1 Compound containing basic group and use thereof |
| 05/03/2007 | WO2007049731A1 Novel cell membrane-permeable peptide |
| 05/03/2007 | WO2007049472A1 Human monoclonal antibody binding to human gm-csf and antigen-binding site thereof |
| 05/03/2007 | WO2007048857A1 Use of tgf-$g(b)1 inhibitor peptides in the preparation of an immune response modulating agent |
| 05/03/2007 | WO2007048847A2 Indole and azaindole derivatives for the treatment of inflammatory and autoimmune diseases |
| 05/03/2007 | WO2007048788A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 05/03/2007 | WO2007048186A1 Leukocyte-binding polypeptides and uses thereof |
| 05/03/2007 | WO2007027528A3 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-.receptor tyrosine kinases |
| 05/03/2007 | WO2007011941A3 Human anti-b7rp1 neutralizing antibodies |
| 05/03/2007 | WO2007009007A3 Methods of treatment using hydroquinone ansamycins |
| 05/03/2007 | WO2006138670A3 Antibody complexes |
| 05/03/2007 | WO2006108556A3 Pharmaceutical aerosol composition |
| 05/03/2007 | WO2006099875A8 Antibodies against cd38 for treatment of multiple myeloma |
| 05/03/2007 | WO2006081276A8 3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity |
| 05/03/2007 | WO2006073496A3 Recombinant aav based vaccine methods |
| 05/03/2007 | US20070099991 Selective rxr ligands |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070099914 Piperidine Derivatives |
| 05/03/2007 | US20070099899 Heterocyclic dihydropyrimidine compounds |
| 05/03/2007 | US20070098808 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases arthritis, skin cancer diabetes, premenstrual syndrome and transdermal transport |
| 05/03/2007 | US20070098747 Topical pharmaceutical composition for the treatment of inflammatory dermatoses |
| 05/03/2007 | US20070098734 loading antigen presenting cells from a subject; loading antigen presenting cells (APC's) having Class I MHC (major histocompatibility factor) molecules with T cell epitopes; culturing CD8+ T cells with APC's; expanding in culture; for allergic asthma, insulin dependent diabetes, arthritis |
| 05/03/2007 | US20070098720 Cd40-binding apc-activating molecules |
| 05/03/2007 | US20070098688 Polymer conjugates of interferon beta-1a and uses |
| 05/03/2007 | CA2627640A1 Therapeutic drug for suppressing functions of nkt cells containing glycolipid derivative as active ingredient |
| 05/03/2007 | CA2627298A1 Use of tgf-.beta.1 inhibitor peptides in the preparation of an immune response modulating agent |
| 05/03/2007 | CA2626565A1 Piperazine derivatives useful as ccr5 antagonists |
| 05/03/2007 | CA2626214A1 Novel use of il-1beta compounds |
| 05/03/2007 | CA2623879A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 05/02/2007 | EP1780285A1 Improved virus like particles (VLP) based on the small envelope protein of hepatitis B virus (HBsAg-S) |
| 05/02/2007 | EP1780277A1 IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons |
| 05/02/2007 | EP1780220A1 Use of CEACAM8-specific substances for treating autoimmune diseases and a method for screening substances which induce apoptosis |
| 05/02/2007 | EP1780201A2 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
| 05/02/2007 | EP1779865A1 Use of human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 05/02/2007 | EP1779859A2 Use of depsipeptide and congeners thereof as immunosuppressants in preventing or treating rejection following transplantation and for induction of apoptosis of activated CD4 or CD8 T-cells |
| 05/02/2007 | EP1779854A1 Glycyrrhizin-containing suppository compositions for rectal infusion |
| 05/02/2007 | EP1779848A1 V-ATPase inhibitors for the treatment of inflammatory and autoimmune diseases |
| 05/02/2007 | EP1778687A2 Fused ring heterocycle kinase modulators |
| 05/02/2007 | EP1778628A1 Organic compounds |
| 05/02/2007 | EP1778286A2 Combination therapy with glatiramer acetate and riluzole |
| 05/02/2007 | EP1778282A1 Mutated hiv nef for modulating immunity |
| 05/02/2007 | EP1778279A1 Pharmaceutical composition containing botulinum neurotoxin a2 |
| 05/02/2007 | EP1778260A2 Potent immunostimulatory extracts from microalgae |
| 05/02/2007 | EP1778246A2 Pharmaceutical composition comprising polymorphic forms of dehydroepiandrosterone |
| 05/02/2007 | EP1778240A2 Dihydropteridinones for the treatment of cancer diseases |
| 05/02/2007 | EP1778223A1 Methods and compositions for reducing toxicity associated with leflunomide treatment |
| 05/02/2007 | EP1778209A1 Methods and compositions for oral delivery of fts |
| 05/02/2007 | EP1778195A2 Anti-histaminic composition |
| 05/02/2007 | EP1549637B1 1- (indol-3-yl)carbonyl piperazine derivatives |
| 05/02/2007 | EP1526870B1 Combination of loteprednoletabonat and dfho for treating respiratory diseases, allergic diseases, asthma and copd |
| 05/02/2007 | EP1494692B1 Topical pharmaceutical compositions comprising proanthocyanidins, glycyrrhetinic acid and telmesteine for the treatment of dermatitis |
| 05/02/2007 | EP1465658B1 ORAL VACCINATION WITH THE TUMOR ANTIGEN MIMOTOPE Gln-Met-Trp-Ala-Pro-Gln-Trp-Gly-Pro-Asp |
| 05/02/2007 | EP1330467B1 Modified, hydroxy-substituted aromatic structures having cytoprotective activity |
| 05/02/2007 | EP1312373B1 Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same |
| 05/02/2007 | EP1280826B1 Polypeptides for inhibiting april-mediated b- and t-cell proliferation. |